The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silverman, G. J.
Right arrow Articles by Curtiss, V. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silverman, G. J.
Right arrow Articles by Curtiss, V. E.
The Journal of Immunology, 1998, 161: 5720-5732.
Copyright © 1998 by The American Association of Immunologists

The Dual Phases of the Response to Neonatal Exposure to a VH Family-Restricted Staphylococcal B Cell Superantigen1

Gregg J. Silverman2, Jayakar V. Nayak3, Klaus Warnatz4, Fred F. Hajjar, Stephen Cary, Helen Tighe and Virginia E. Curtiss

The Sam and Rose Stein Institute for Research on Aging and the Theodore Gildred Cancer Center, Department of Medicine, University of California at San Diego, La Jolla, CA 92093

In vitro studies of several naturally occurring proteins have characterized VH family-specific B lymphocyte binding and stimulatory properties that appear analogous to those of T cell superantigens. To examine the in vivo consequences of exposure to a putative B cell superantigen, we treated neonatal BALB/c mice with a form of staphylococcal protein A (MS) devoid of Fc{gamma} binding activity, which retains the clan VHIII Fab binding specificity. In naive adults, about 5% of peripheral B cells and >13% of splenic IgM-secreting cells display MS binding activity, in association with high IgM and low IgG circulating anti-MS Ab titers. Neonatal exposure to MS elicited two distinct temporal phases of immune responsiveness. The early phase, representing the first approximately 5 wk of life, was associated with MS-specific B cell and T cell tolerance. Microfluorometric assays revealed that exposure caused a dramatic MS-specific B cell clonal loss in bone marrow and spleen, but levels normalized by about 3 wk of life. The late phase (>6 wk of age) was associated with spontaneous priming for MS-specific T cell responses and production of MS-specific IgG1 Abs despite long term persistently depressed in vivo and in vitro MS-specific IgM responses. In vivo challenge during the late phase induced high frequencies of MS-specific IgG-secreting cells, indicating recruitment of highly focused Ab responses that were predominantly encoded by rearrangements of the S107 family, a member of the VHIII clan. These studies document the immunodominance of the VH-restricted Fab binding site on staphylococcal protein A and demonstrate the diverse effects of a B cell superantigen on the emerging peripheral B cell compartment.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. E. Butler, N. Wertz, P. Weber, and K. M. Lager
Porcine Reproductive and Respiratory Syndrome Virus Subverts Repertoire Development by Proliferation of Germline-Encoded B Cells of All Isotypes Bearing Hydrophobic Heavy Chain CDR3
J. Immunol., February 15, 2008; 180(4): 2347 - 2356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Bekeredjian-Ding, S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zahringer, and G. Hartmann
Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands
J. Immunol., March 1, 2007; 178(5): 2803 - 2812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. S. Goodyear, F. Sugiyama, and G. J. Silverman
Temporal and Dose-Dependent Relationships between In Vivo B Cell Receptor-Targeted Proliferation and Deletion-Induced by a Microbial B Cell Toxin
J. Immunol., February 15, 2006; 176(4): 2262 - 2271.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Goodyear and G. J. Silverman
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes
PNAS, August 3, 2004; 101(31): 11392 - 11397.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. S. Goodyear, M. Narita, and G. J. Silverman
In Vivo VL-Targeted Activation-Induced Apoptotic Supraclonal Deletion by a Microbial B Cell Toxin
J. Immunol., March 1, 2004; 172(5): 2870 - 2877.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. S. Goodyear and G. J. Silverman
Death by a B Cell Superantigen: In Vivo VH-targeted Apoptotic Supraclonal B Cell Deletion by a Staphylococcal Toxin
J. Exp. Med., May 5, 2003; 197(9): 1125 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. H. Lucas, K. D. Moulton, V. R. Tang, and D. C. Reason
Combinatorial Library Cloning of Human Antibodies to Streptococcus pneumoniae Capsular Polysaccharides: Variable Region Primary Structures and Evidence for Somatic Mutation of Fab Fragments Specific for Capsular Serotypes 6B, 14, and 23F
Infect. Immun., February 1, 2001; 69(2): 853 - 864.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. J. Silverman, S. P. Cary, D. C. Dwyer, L. Luo, R. Wagenknecht, and V. E. Curtiss
A B Cell Superantigen-induced Persistent "Hole" in the B-1 Repertoire
J. Exp. Med., July 3, 2000; 192(1): 87 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff
Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells
J. Immunol., May 15, 2000; 164(10): 5482 - 5491.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Graille, E. A. Stura, A. L. Corper, B. J. Sutton, M. J. Taussig, J.-B. Charbonnier, and G. J. Silverman
Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity
PNAS, May 9, 2000; 97(10): 5399 - 5404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Cary, J. Lee, R. Wagenknecht, and G. J. Silverman
Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface
J. Immunol., May 1, 2000; 164(9): 4730 - 4741.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. N. Neshat, L. Goodglick, K. Lim, and J. Braun
Mapping the B cell superantigen binding site for HIV-1 gp120 on a VH3 Ig
Int. Immunol., March 1, 2000; 12(3): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Karray, L. Juompan, R. C. Maroun, D. Isenberg, G. J. Silverman, and M. Zouali
Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins
J. Immunol., December 15, 1998; 161(12): 6681 - 6688.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.